• Activity INFORMATION

  Overview

  In a podcast style discussion, Mike Corvino, PharmD and Cole Swanson, PharmD examine the treatment and management of atopic dermatitis.  Many new treatment options for atopic dermatitis have come to market and can be beneficial to certain patients.  There are other therapies being studied that are set to be approved in the near future as well. Atopic dermatitis is a very common condition and pharmacists and nurses regularly encounter affected patients. It is important that pharmacists and nurses understand the appropriate use of the relevant medications and know how to identify patients who could benefit from them.  This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice.  

  Access the original podcast here.

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify side effects and risks associated with the medications

  Recognize risk factors for the development of atopic dermatitis

  Identify the pathogenesis and clinical manifestations of atopic dermatitis

  Recognize the therapeutic targets of newer biologic therapies used to treat atopic dermatitis

  Differentiate old and new treatment options for atopic dermatitis

  Nurse

  Recognize risk factors for the development of atopic dermatitis

  Differentiate old and new treatment options for atopic dermatitis

  Recognize the therapeutic targets of newer biologic therapies used to treat atopic dermatitis

  Identify the pathogenesis and clinical manifestations of atopic dermatitis

  Identify side effects and risks associated with the medications

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-911160

  Universal Activity Number

  Pharmacist 0798-0000-22-130-H01-P
  Nurse 0798-0000-22-130-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).